annual EBITDA:
-$94.81M-$6.88M(-7.82%)Summary
- As of today (July 11, 2025), ALT annual EBITDA is -$94.81 million, with the most recent change of -$6.88 million (-7.82%) on December 31, 2024.
- During the last 3 years, ALT annual EBITDA has risen by +$1.72 million (+1.78%).
- ALT annual EBITDA is now -29246.02% below its all-time high of $325.30 thousand, reached on December 31, 2005.
Performance
ALT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$20.23M+$2.92M(+12.62%)Summary
- As of today (July 11, 2025), ALT quarterly EBITDA is -$20.23 million, with the most recent change of +$2.92 million (+12.62%) on March 1, 2025.
- Over the past year, ALT quarterly EBITDA has increased by +$4.06 million (+16.72%).
- ALT quarterly EBITDA is now -999.69% below its all-time high of $2.25 million, reached on June 30, 2007.
Performance
ALT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$90.75M+$4.06M(+4.28%)Summary
- As of today (July 11, 2025), ALT TTM EBITDA is -$90.75 million, with the most recent change of +$4.06 million (+4.28%) on March 1, 2025.
- Over the past year, ALT TTM EBITDA has increased by +$1.52 million (+1.65%).
- ALT TTM EBITDA is now -10148.94% below its all-time high of $903.10 thousand, reached on June 30, 2006.
Performance
ALT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ALT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.8% | +16.7% | +1.6% |
| 3 y3 years | +1.8% | -5.1% | +10.2% |
| 5 y5 years | -369.6% | -186.6% | -125.4% |
ALT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.3% | +1.8% | -26.9% | +35.8% | -16.7% | +12.1% |
| 5 y | 5-year | -369.6% | +1.8% | -92.3% | +39.1% | -125.4% | +12.1% |
| alltime | all time | <-9999.0% | +1.8% | -999.7% | +39.1% | <-9999.0% | +12.1% |
ALT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$20.23M(-12.6%) | -$90.75M(-4.3%) |
| Dec 2024 | -$94.81M(+7.8%) | -$23.15M(+1.5%) | -$94.81M(-8.1%) |
| Sep 2024 | - | -$22.80M(-7.2%) | -$103.19M(+2.3%) |
| Jun 2024 | - | -$24.58M(+1.2%) | -$100.91M(+9.4%) |
| Mar 2024 | - | -$24.29M(-23.0%) | -$92.27M(+4.9%) |
| Dec 2023 | -$87.94M(+4.2%) | -$31.52M(+53.6%) | -$87.94M(+13.0%) |
| Sep 2023 | - | -$20.52M(+28.8%) | -$77.79M(-3.9%) |
| Jun 2023 | - | -$15.94M(-20.1%) | -$80.92M(-4.8%) |
| Mar 2023 | - | -$19.95M(-6.7%) | -$84.97M(+0.8%) |
| Dec 2022 | -$84.41M(-12.6%) | -$21.38M(-9.6%) | -$84.27M(-2.8%) |
| Sep 2022 | - | -$23.65M(+18.3%) | -$86.72M(-9.9%) |
| Jun 2022 | - | -$19.99M(+3.8%) | -$96.26M(-4.7%) |
| Mar 2022 | - | -$19.25M(-19.2%) | -$101.00M(+4.6%) |
| Dec 2021 | -$96.53M(+78.7%) | -$23.83M(-28.2%) | -$96.53M(+16.0%) |
| Sep 2021 | - | -$33.19M(+34.2%) | -$83.22M(+22.0%) |
| Jun 2021 | - | -$24.73M(+67.3%) | -$68.21M(+10.5%) |
| Mar 2021 | - | -$14.78M(+40.5%) | -$61.74M(+14.3%) |
| Dec 2020 | -$54.02M(+167.6%) | -$10.52M(-42.1%) | -$54.02M(+13.7%) |
| Sep 2020 | - | -$18.18M(-0.5%) | -$47.53M(+18.1%) |
| Jun 2020 | - | -$18.27M(+158.9%) | -$40.26M(+59.1%) |
| Mar 2020 | - | -$7.06M(+75.3%) | -$25.30M(+25.3%) |
| Dec 2019 | -$20.19M(-54.9%) | -$4.03M(-63.1%) | -$20.19M(-53.3%) |
| Sep 2019 | - | -$10.91M(+229.5%) | -$43.26M(+22.6%) |
| Jun 2019 | - | -$3.31M(+70.4%) | -$35.28M(-17.1%) |
| Mar 2019 | - | -$1.94M(-92.8%) | -$42.54M(-4.9%) |
| Dec 2018 | -$44.72M(-13.6%) | -$27.10M(+825.3%) | -$44.72M(+51.5%) |
| Sep 2018 | - | -$2.93M(-72.3%) | -$29.52M(-49.1%) |
| Jun 2018 | - | -$10.57M(+156.2%) | -$57.99M(+12.8%) |
| Mar 2018 | - | -$4.12M(-65.3%) | -$51.39M(-0.7%) |
| Dec 2017 | -$51.76M(+374.3%) | -$11.90M(-62.1%) | -$51.76M(+20.7%) |
| Sep 2017 | - | -$31.40M(+691.2%) | -$42.88M(+164.0%) |
| Jun 2017 | - | -$3.97M(-11.7%) | -$16.24M(+17.4%) |
| Mar 2017 | - | -$4.49M(+48.5%) | -$13.84M(+31.0%) |
| Dec 2016 | -$10.91M(+1426.3%) | -$3.02M(-36.4%) | -$10.56M(+25.5%) |
| Sep 2016 | - | -$4.76M(+203.6%) | -$8.42M(+73.1%) |
| Jun 2016 | - | -$1.57M(+28.8%) | -$4.87M(-12.8%) |
| Mar 2016 | - | -$1.22M(+38.1%) | -$5.58M(+98.1%) |
| Dec 2015 | -$715.00K | -$880.80K(-26.7%) | -$2.82M(-43.5%) |
| Sep 2015 | - | -$1.20M(-47.3%) | -$4.99M(-40.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2015 | - | -$2.28M(-247.5%) | -$8.30M(+30.2%) |
| Mar 2015 | - | $1.55M(-150.7%) | -$6.38M(-36.5%) |
| Dec 2014 | -$10.04M(-9.6%) | -$3.05M(-32.5%) | -$10.04M(-11.0%) |
| Sep 2014 | - | -$4.52M(+1180.3%) | -$11.28M(+7.0%) |
| Jun 2014 | - | -$353.00K(-83.3%) | -$10.55M(-6.5%) |
| Mar 2014 | - | -$2.12M(-50.6%) | -$11.28M(+10.6%) |
| Dec 2013 | -$11.11M(+171.2%) | -$4.29M(+13.5%) | -$10.20M(+45.7%) |
| Sep 2013 | - | -$3.78M(+249.2%) | -$7.00M(+117.1%) |
| Jun 2013 | - | -$1.08M(+4.4%) | -$3.22M(+19.7%) |
| Mar 2013 | - | -$1.04M(-5.3%) | -$2.69M(-34.2%) |
| Dec 2012 | -$4.10M(+24.8%) | -$1.10M(>+9900.0%) | -$4.10M(+92.8%) |
| Sep 2012 | - | -$6900.00(-98.8%) | -$2.12M(+4.8%) |
| Jun 2012 | - | -$552.60K(-77.4%) | -$2.03M(-46.4%) |
| Mar 2012 | - | -$2.44M(-378.8%) | -$3.78M(+15.2%) |
| Dec 2011 | -$3.28M(-85.9%) | $875.50K(+863.1%) | -$3.28M(-72.3%) |
| Sep 2011 | - | $90.90K(-103.9%) | -$11.86M(-21.2%) |
| Jun 2011 | - | -$2.31M(+18.7%) | -$15.06M(-16.5%) |
| Mar 2011 | - | -$1.94M(-74.8%) | -$18.04M(-22.4%) |
| Dec 2010 | -$23.26M(-7.4%) | -$7.71M(+148.1%) | -$23.26M(+8.9%) |
| Sep 2010 | - | -$3.11M(-41.2%) | -$21.36M(-16.3%) |
| Jun 2010 | - | -$5.28M(-26.2%) | -$25.53M(-4.8%) |
| Mar 2010 | - | -$7.16M(+23.2%) | -$26.82M(+7.4%) |
| Dec 2009 | -$25.10M(+37.2%) | -$5.81M(-20.2%) | -$24.98M(+5.1%) |
| Sep 2009 | - | -$7.28M(+10.8%) | -$23.77M(+18.7%) |
| Jun 2009 | - | -$6.57M(+23.5%) | -$20.03M(+6.0%) |
| Mar 2009 | - | -$5.32M(+15.7%) | -$18.90M(+3.3%) |
| Dec 2008 | -$18.30M(+15.8%) | -$4.60M(+29.8%) | -$18.29M(-2.9%) |
| Sep 2008 | - | -$3.54M(-35.0%) | -$18.83M(+0.6%) |
| Jun 2008 | - | -$5.44M(+15.6%) | -$18.72M(+69.8%) |
| Mar 2008 | - | -$4.71M(-8.4%) | -$11.02M(+23.6%) |
| Dec 2007 | -$15.80M(+12.4%) | -$5.14M(+50.0%) | -$8.92M(+3.4%) |
| Sep 2007 | - | -$3.43M(-252.4%) | -$8.63M(+1.8%) |
| Jun 2007 | - | $2.25M(-186.4%) | -$8.48M(-18.4%) |
| Mar 2007 | - | -$2.60M(-46.3%) | -$10.39M(+37.6%) |
| Dec 2006 | -$14.05M(-4419.1%) | -$4.85M(+48.0%) | -$7.55M(+198.4%) |
| Sep 2006 | - | -$3.28M(-1069.4%) | -$2.53M(-380.0%) |
| Jun 2006 | - | $337.90K(+42.3%) | $903.10K(+59.8%) |
| Mar 2006 | - | $237.40K(+38.6%) | $565.20K(+72.4%) |
| Dec 2005 | $325.30K | $171.30K(+9.5%) | $327.80K(+109.5%) |
| Sep 2005 | - | $156.50K | $156.50K |
FAQ
- What is Altimmune, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Altimmune, Inc.?
- What is Altimmune, Inc. annual EBITDA year-on-year change?
- What is Altimmune, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Altimmune, Inc.?
- What is Altimmune, Inc. quarterly EBITDA year-on-year change?
- What is Altimmune, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Altimmune, Inc.?
- What is Altimmune, Inc. TTM EBITDA year-on-year change?
What is Altimmune, Inc. annual EBITDA?
The current annual EBITDA of ALT is -$94.81M
What is the all time high annual EBITDA for Altimmune, Inc.?
Altimmune, Inc. all-time high annual EBITDA is $325.30K
What is Altimmune, Inc. annual EBITDA year-on-year change?
Over the past year, ALT annual EBITDA has changed by -$6.88M (-7.82%)
What is Altimmune, Inc. quarterly EBITDA?
The current quarterly EBITDA of ALT is -$20.23M
What is the all time high quarterly EBITDA for Altimmune, Inc.?
Altimmune, Inc. all-time high quarterly EBITDA is $2.25M
What is Altimmune, Inc. quarterly EBITDA year-on-year change?
Over the past year, ALT quarterly EBITDA has changed by +$4.06M (+16.72%)
What is Altimmune, Inc. TTM EBITDA?
The current TTM EBITDA of ALT is -$90.75M
What is the all time high TTM EBITDA for Altimmune, Inc.?
Altimmune, Inc. all-time high TTM EBITDA is $903.10K
What is Altimmune, Inc. TTM EBITDA year-on-year change?
Over the past year, ALT TTM EBITDA has changed by +$1.52M (+1.65%)